Ruling out the possibility of heart failure in the primary care setting using B-type type natriuretic peptide testing is proving cost-effective both for the GP and the laboratory. Hilda Crockett reports on the Northampton experience.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.